This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lu, X. Articles by Gershengorn, M. C. Search for Related Content PubMed PubMed Citation Articles by Lu, X. Articles by Gershengorn, M. C.

Pharmacological Studies of Thyrotropin-Releasing Hormone (TRH) Receptors from Xenopus laevis: Is xTRHR3 a TRH Receptor?

National Institute of Diabetes and Digestive and Kidney Diseases (X.L., M.C.G.), National Institutes of Health, Bethesda, Maryland 20892; and Laboratoire de Bioactivation des Peptides (I.B., A.L.), Institut Jacques Monod, Unité Mixte de Recherche 7592, Centre National de la Recherche Scientifique-Universite Paris 6/7, 75251 Paris cedex 05, France

Address all correspondence and requests for reprints to: Marvin C. Gershengorn, Scientific Director, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 9000 Rockville Pike, Building 50/4128, Bethesda, Maryland 20892-1818. E-mail: marving{at}intra.niddk.nih.gov.

Previously, three receptors, xTRHR1, xTRHR2, and xTRHR3, were cloned from brain tissue of Xenopus laevis with primers designed using sequences from the mammalian TRH receptor (TRHR) subtype 1. We expressed the Xenopus receptors in HEK 293EM cells and studied their binding and signaling properties using a series of TRH analogs substituted at the first, second, and third positions. We observed that the three Xenopus receptors exhibited binding and signaling properties that were distinct. Although xTRHR1 was most similar to mouse TRHR1 (mTRHR1), it exhibited binding affinities that were different from mTRHR1. In contrast to mTRHR2, xTRHR2 exhibited lower affinities and potencies for all TRH analogs than mTRHR1. The xTRHR3 displayed very low affinities and potencies for TRH and TRH analogs and showed little discrimination for TRH analogs; it is likely, therefore, that another peptide is the cognate ligand for xTRHR3. Our findings show differences between TRHR1 and TRHR2 from Xenopus and mammals and suggest that xTRHR3 is a receptor for a ligand other than TRH.